Innovation & Collaboration: 2022 Advances in Musculoskeletal Oncology Symposium

Fort Lauderdale, FL US
January 27, 2022 to January 28, 2022

Musculoskeletal oncology is constantly evolving with many varied treatment techniques applicable to many subspecialties. The providers, while focusing on their specialty must also be aware of new and evolving technologies and treatment techniques in subspecialties other than their own. The conference is intended to enhance the overall fund of knowledge required for these providers to treat patients in all subspecialties and to inform their colleagues on the availability and quality delivery of these technologies. With such emerging technologies, treatment techniques and clinical research trials, it is imperative that providers be aware of the best options for the patients they may encounter.  This CE will address the gaps in these treatments, protocols and technologies to ensure the resources that are available to all providers is recognized in order to optimally collaborate care for each patient.


Keywords: Sarcoma, Musculoskeletal, connective tissue, neoplasm, healthcare delivery, patient care team, quality of life

Target Audience

  • Radiation Oncologists
  • Medical Oncologists
  • Surgical Oncologists
  • Radiologists
  • Pathologists
  • Residents
  • Medical Students
  • Advanced Practice Providers

Learning Objectives

Participants who engage in this educational intervention will be able to:

  • Identify integral roles of the multidisciplinary team to be able to provide optimal care of musculoskeletal oncology patients.
  • Describe current clinical trials in musculoskeletal oncology/novel agents in sarcoma. Attendees will be provided links to websites with up-to-date clinical trial information, to be able to best advise patients and increase enrollment in these trials.
  • Appraise minimally-invasive options for patients with metastatic bone disease, including candidacy and workup.  A panel discussion will reinforce and clarify learning. 
  • Critically review the data in latest management options, and potentially contribute to future research strategies by discussing with experts in this field.
  • Create new networking opportunities with other health care providers, trainees and pharmaceutical partners. 
  • Develop collaborations that will lead to improve clinic trial portfolio and clinical trial participation. 
Additional information


Jodi Franklin
Phone Number: 
+1 (414) 805-4488
Course summary
Available credit: 
  • 8.50 AMA PRA Category 1 Credit(s)™
    AMA PRA Category 1 Credit(s)™
  • 8.50 Hours of Participation
    Hours of Participation credit.
Course opens: 
Course expires: 
Event starts: 
01/27/2022 - 1:00pm CST
Event ends: 
01/28/2022 - 4:00pm CST
W Fort Lauderdale
401 N Fort Lauderdale Blvd
Fort Lauderdale, FL 33304
United States

In accordance with the ACCME® Standards for Integrity and Independence in Accredited Continuing Education, Standard 3, all in control of content must disclose any relevant financial relationships. The following in control of content had no relevant financial relationships to disclose.

John C Neilson

Gina D Amato

Danny Indelicato

Reena Singh

David King

Dennis Ian English

Callisia Clarke

Manpreet Bedi

Brandon Key

Andrew Rosenberg

Raphael Yechieli 

Dao Nguyen



The following persons in control of content disclosed the following financial relationships which were reviewed via the MCW conflict of interest mitigation process and addressed.




Sean M Tutton, MDBoston Scientific/ BTG/ GalilConsulting

Robert G Maki, MD, PhD

Glaxo S
Smith Kline
Peel Therapeutics
PER: Physicians' Education Resource
American Board of Internal Medicine
American Society for Clinical Oncology 
Consulting fees
Adam Woolridge, MD MPH

Musculoskeletal Tumor Foundation


Francis J Hornicek


Stryker Medical Devices

Bone Solutions Inc.

Globus Medical

Government Drug Regulation- Safety Committee Member



Royalties on Colloseum Anterior Cage

Susan V Bukata







John CharlsonDecipheraConsultant
ACCME Accreditation Statement:
The Medical College of Wisconsin is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
AMA Credit Designation Statement:
The Medical College of Wisconsin designates this live activity for a maximum of 8.5 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Hours of Participation for Allied Health Care Professionals:
The Medical College of Wisconsin designates this activity for up to 8.5 hours of participation for continuing education for allied health professionals.


Available Credit

  • 8.50 AMA PRA Category 1 Credit(s)™
    AMA PRA Category 1 Credit(s)™
  • 8.50 Hours of Participation
    Hours of Participation credit.


Please login or register to take this course.